National Advocacy and Legislation

Home Archive "National Advocacy and Legislation"
AKSAM-Sends-Letter-to-Congress-To-Raise-Legal-Tobacco-Age-to-21-Years
Articles of Interest Local Advocacy & Legislation National Advocacy and Legislation

AKSAM Sends Letter to Congress to Raise Tobacco Use and Possession Age to 21

On March 12, the Alaska Society of Addiction Medicine (AKSAM) sent a letter of support for HB49/SB24 to members of the Senate Committee on Labor and Business. HB49/SB24 would strengthen youth tobacco prevention efforts by raising the minimum age for purchase and possession to 21. In the letter, AKSAM affirmed its support for an approach to tobacco prevention that aims to reduce youth...
Updates to rules for Opioid Treatment Programs: The 42 CFR Part 8 Final Rule Table of Changes
Guidelines and Publications National Advocacy and Legislation

Updates to rules for Opioid Treatment Programs: The 42 CFR Part 8 Final Rule Table of Changes

The following table summarizes some key changes to 42 CFR part 8. This table does not discuss all changes. To review all of the changes to 42 CFR part 8, interested parties are encouraged to view the final rule. For questions regarding implementation of the final rule, please contact SAMHSA’s Division of Pharmacologic Therapies at 240-276-2700 or DPT@samhsa.hhs.gov or your State...
DEA Announces Three New Telemedicine Rules that Continue to Open Access to Telehealth Treatment while Protecting Patients
Articles of Interest National Advocacy and Legislation

DEA Announces Three New Telemedicine Rules that Continue to Open Access to Telehealth Treatment while Protecting Patients

WASHINGTON – The U.S. Drug Enforcement Administration is announcing three new rules to make permanent some temporary telemedicine flexibilities established during the COVID-19 public health emergency while also establishing new patient protections.  In developing these rules, DEA has focused on the patient to ensure telemedicine is accessible for medical care. Importantly, these rules...
SAMHSA Updates Guidelines for Contingency Management: Incentives Increased to $750
Guidelines and Publications National Advocacy and Legislation

SAMHSA Updates Guidelines for Contingency Management: Incentives Increased to $750

Background CM is a health care intervention in which tangible reinforcers, or motivational incentives, are givento participants contingent on objective evidence of change in a specific, incentivized behavior. CM is widely studied and has been successful in treating a variety of SUDs in diverse populations, and with demonstrated long-term benefit (a median of 24 weeks after...